Antecedent Hyperglycemia, Not Hyperlipidemia, Is Associated with Increased Islet Triacylglycerol Content and Decreased Insulin Gene mRNA Level in Zucker Diabetic Fatty Rats

Diabetes

Volumn 50, Issue 7-12, 2001, Pages 2481-2486

  Harmon, Jamie S ^a,b   Gleason, Catherine E ^a   Tanaka, Yoshito ^a   Poitout, Vincent ^a   Robertson, R Paul ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b PACIFIC NORTHWEST RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARRIER PROTEIN; CELL SURFACE RECEPTOR; INSULIN; LEPTIN RECEPTOR; MESSENGER RNA; TRIACYLGLYCEROL;

ALLELE; ANIMAL; ARTICLE; BODY WEIGHT; DIABETES MELLITUS; GENETICS; HETEROZYGOTE; HYPERGLYCEMIA; HYPERLIPIDEMIA; MALE; METABOLISM; MUTATION; OBESITY; PANCREAS ISLET; PHYSIOLOGY; RAT; ZUCKER RAT;

ALLELES; ANIMALS; CARRIER PROTEINS; DIABETES MELLITUS; HETEROZYGOTE; HYPERGLYCEMIA; HYPERLIPIDEMIAS; INSULIN; ISLETS OF LANGERHANS; MALE; MUTATION; OBESITY; RATS; RATS, ZUCKER; RECEPTORS, CELL SURFACE; RNA, MESSENGER; THINNESS; TRIGLYCERIDES;

EID: 0035514684     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.50.11.2481     Document Type: Article

References (42)

1. Robertson RP, Olson LK, Zhang H-J: Differentiating glucose toxicity from glucose desensitization: a new message from the insulin gene. Diabetes 43:1085-1089, 1994
2. Harmon JS, Gleason CE, Tanaka Y, Oseid EA, Hunter-Berger KK, Robertson RP: In vivo prevention of hyperglycemia also prevents glucotoxic effects on PDX-1 and insulin gene expression. Diabetes 48:1995-2000, 1999
3. Kaneto H, Kajimoto Y, Miyagawa J-I, Matsuoka T-A, Fujitani Y, Umayahara Y, Hanafusa T, Matsuzawa Y, Yamasaki Y, Hori M: Beneficial effects of antioxidants in diabetes: possible protection of pancreatic β-cells against glucose toxicity. Diabetes 48:2398-2406, 1999
4. Seufert J, Weir GC, Habener JF: Differential expression of the insulin gene transcriptional repressor CCAAT/enhancer-binding protein β and transactivator islet duodenum homeobox-1 in rat pancreatic β cells during the development of diabetes mellitus. J Clin Invest 101:2528-2539, 1998
5. Tokuyama Y, Sturis J, DePaoli AM, Takeda J, Stoffel M, Tang J, Sun X, Polonsky KS, Bell GI: Evolution of β-cell dysfunction in the male Zucker diabetic fatty rat. Diabetes 44:1447-1457, 1995
6. Lee Y, Hirose H, Ohneda M, Johnson JH, McGarry JD, Unger RH: β-cell lipotoxicity in the pathogenesis of non-insulin-dependent diabetes mellitus of obese rats: impairment in adipocyte-β-cell relationships. Proc Natl Acad Sci U S A 91:10878-10882, 1994
7. Lee Y, Hirose H, Zhou Y-T, Esser V, McGarry JD, Unger RH: Increased lipogenic capacity of the islets of obese rats: a role in the pathogenesis of NIDDM. Diabetes 46:408-413, 1997
8. Unger RH: Lipotoxicity in the pathogenesis of obesity-dependent NIDDM. Diabetes 44:863-870, 1995
9. Unger RH: How obesity causes diabetes in Zucker diabetic fatty rats. Trends Endocrinol Metab 7:276-282, 1998
10. Zhou Y-P, Ling Z-C, Grill VE: Inhibitory effects of fatty acids on glucose-regulated B-cell function: association with increased islet triglyceride stores and altered effect of fatty acid oxidation on glucose metabolism. Metabolism 45:981-1986, 1996
11. Briaud I, Harmon JS, Kelpe CL, Segu VB, Poitout V: Lipotoxicity of the pancreatic β-cell is associated with glucose-dependent esterification of fatty acids into neutral lipids. Diabetes 50:315-321, 2001
12. Zhou Y-P, Grill V: Long-term exposure of rat pancreatic islets to fatty acids inhibits glucose induced insulin secretion and biosynthesis through a glucose fatty acid cycle. J Clin Invest 93:870-876, 1994
13. Jacqueminet S, Briaud I, Rouault C, Reach G, Poitout V: Inhibition of insulin gene expression by long-term exposure of pancreatic β cells to palmitate is dependent on the presence of a stimulatory glucose concentration. Metabolism 49:532-536, 2000
14. Higa M, Zhou Y-T, Ravazzola M, Baetens D, Orci L, Unger RH: Troglitazone prevents mitochondrial alterations, β cell destruction, and diabetes in obese prediabetic rats. Proc Natl Acad Sci U S A 96:11513-11518, 1999
15. Shimabukuro M, Koyama K, Lee Y, Unger RH: Leptin- or troglitazone-induced lipopenia protects islets from interleukin 1β cytotoxicity. J Clin Invest 100:1750-1754, 1997
16. Schoonjans K, Staels B, Auwerx J: Role of the peroxisome proliferator-activated receptor (PPAR) in mediating the effects of fibrates and fatty acids on gene expression. J Lipid Res 37:907-925, 1996
17. Phillips M, Liu Q, Hammond H, Dugan V, Hey P, Caskey C, Hess J: Leptin receptor missense mutation in the fatty Zucker rat. Nat Genet 13:18-19, 1996
18. Chomczynski P, Sacchi N: Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162: 156-159, 1987
19. Tanaka Y, Gleason CE, Tran POT, Harmon JS, Robertson RP: Prevention of glucose toxicity in HIT-T15 cells and Zucker diabetic fatty rats by antioxidants. Proc Natl Acad Sci U S A 96:10857-10862, 1999
20. Unger RH, Grundy S: Hyperglycaemia as an inducer as well as a consequence of impaired islet cell function and insulin resistance: implications for the management of diabetes. Diabetologia 28:119-121, 1985
21. Rossetti L, Shulman GI, Zawalich W, DeFronzo RA: Effect of chronic hyperglycemia on in vivo insulin secretion in partially pancreatectomized rats. J Clin Invest 80:1307-1044, 1987
22. Yki-Jarvinen H: Glucose toxicity. Endocr Rev 13:415-431, 1992
23. Leahy JL, Bonner-Weir S, Weir GC: β-cell dysfunction induced by chronic hyperglycemia. Diabetes Care 15:442-455, 1992
24. Ling Z, Kiekens R, Mahler T, Schuit FC, Pipeleers-Marichal M, Sener A, Kloppel G, Malaisse WJ, Pipeleers DG: Effects of chronically elevated glucose levels on the functional properties of rat pancreatic beta-cells. Diabetes 45:1774-1782, 1996
25. Eizirik DL, Korbutt GS, Hellerstrom C: Prolonged exposure of human pancreatic islets to high glucose concentrations in vitro impairs the β-cell function. J Clin Invest 90:1263-1268, 1992
26. Robertson RP, Zhang H-J, Pyzdrowski KL, Walseth TF: Preservation of insulin mRNA levels and insulin secretion in HIT cells by avoidance of chronic exposure to high glucose concentrations. J Clin Invest 90:320-325, 1992
27. Lu M, Seufert J, Habener JF: Pancreatic β-cell-specific repression of insulin gene transcription by CCAAT/enhancer-binding protein β. J Biol Chem 272:28349-28359, 1997
28. Robertson RP, Harmon J, Tanaka Y, Sacchi G, Tran PO, Gleason C, Poitout V: Glucose toxicity of the β-cell. In Diabetes Mellitus: A Fundamental and Clinical Text. LeRoith D, Taylor SI, Olefsky JM, Eds. Philadelphia, Lippincott Williams & Wilkins, 2000, p. 125-132
29. Listenberger LL, Ory DS, Shaffer JE: Palmitate-induced apoptosis can occur through a ceramide-independent pathway. J Biol Chem 276:14890-14895, 2001
30. Unger RH, Zhou Y-T, Orci L: Lipotoxicity. In Diabetes Mellitus: A Fundamental and Clinical Text. Roith DL, Taylor SI, Olefsky JM, Eds. Philadelphia, Lippincott Williams & Wilkins, 2000, p. 132-141
31. Gremlich S, Bonny C, Waeber G, Thorens B: Fatty acids decrease IDX-1 expression in rat pancreatic islets and reduce GLUT2, glucokinase, insulin, and somatostatin levels. J Biol Chem 272:30261-30269, 1997
32. Prentki M, Corkey BE: Are the β-cell signaling molecules malonyl-CoA and cytosolic long-chain acyl-CoA implicated in multiple tissue defects of obesity and NIDDM? Diabetes 45:273-283, 1996
33. Pick A, Clark J, Kubstrup C, Levisetti M, Pugh W, Bonner-Weir S, Polonsky KS: Role of apoptosis in failure of beta-cell mass compensation for insulin resistance and beta-cell defects in the male Zucker diabetic fatty rat. Diabetes 47:358-364, 1998
34. Ohneda M, Johnson JH, Lee YH, Nagasawa Y, Unger RH: Post-GLUT2 defects in β-cells of non-insulin-dependent diabetic obese rats. Am J Physiol 267:E968-E974, 1994
35. Jonas J-C, Sharma A, Hasenkamp W, Ilkova H, Patane G, Laybutt R, Bonner-Weir S, Weir GC: Chronic hyperglycemia triggers loss of pancreatic β cell differentiation in an animal model of diabetes. J Biol Chem 274: 14112-14121, 1999
36. Rossetti L, Smith D, Shulman GI, Papachristou D, DeFronzo RA: Correction of hyperglycemia with phlorizin normalizes tissue sensitivity to insulin in diabetic rats. J Clin Invest 79:1510-1515, 1987
37. Zambon A, Hashimoto SI, Brunzell JD: Analysis of techniques to obtain plasma for measurement of levels of free fatty acids. J Lipid Res 34:1021-1028, 1993
38. Hasegawa N, Ogawa Y, Tazawa Y, Umeda Y, Katayama Y, Nakamura T, Suda T: Beneficial effects of bezafibrate on glucose tolerance and insulin secretion in rats with type 2 diabetes mellitus. Diabetologia 43:501, 2000
39. Berne C: The metabolism of lipids in mouse pancreatic islets: the biosynthesis of triacylglycerols and phospholipids. Biochem J 152:667-673, 1975
40. Zhou Y-P, Grill V: Long term exposure to fatty acids and ketones inhibits B-cell functions in human pancreatic islets of Langerhans. J Clin Endocr Metab 80:1584-1590, 1995
41. Roche E, Farfari S, Witters LA, Assimacopoulos-Jeannet F, Thumelin S, Brun T, Corkey BE, Saha AK, Prentki M: Long-term exposure of β-INS cells to high glucose concentrations increases anaplerosis, lipogenesis, and lipogenic gene expression. Diabetes 47:1086-1094, 1998
42. Shimabukuro M, Zhou Y-T, Levi M, Unger RH: Fatty acid-induced β cell apoptosis: a link between obesity and diabetes. Proc Natl Acad Sci U S A 95:2498-2502, 1998